Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hofseth BioCare ASAHOFBF 60 3-Year EPS without NRI Growth Rate is 3.70% as of Jun. 2026. GuruFocus rates HOFBF with a GF Score™ of 60/100 and a GF Value™ of $0.23. The stock has 5 warning signs investors should review. Among 1,533 Consumer Packaged Goods companies, Hofseth BioCare ASA ranks worse than 55.58% on this metric.
During the past 3 years, the average EPS without NRI Growth Rate was 3.70% per year.
During the past 5 years, the average EPS without NRI Growth Rate was 0.20% per year.
During the past 10 years, the average EPS without NRI Growth Rate was 4.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Hofseth BioCare ASA was 54.20% per year. The lowest was -64.20% per year. And the median was -2.10% per year.
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Hofseth BioCare ASA 3-Year EPS without NRI Growth Rate Related Terms
HOFBF vs KHC, GIS, MKC: 3-Year EPS without NRI Growth Rate Comparison
For the Packaged Foods subindustry, Hofseth BioCare ASA's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hofseth BioCare ASA 3-Year EPS without NRI Growth Rate vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Hofseth BioCare ASA's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Hofseth BioCare ASA's 3-Year EPS without NRI Growth Rate falls into.
Hofseth BioCare ASA 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 3.70% mean?
Hofseth BioCare ASA (HOFBF) has a 3-Year EPS without NRI Growth Rate of 3.70% as of Jun. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Hofseth BioCare ASA and its competitors. According to the industry distribution chart, Hofseth BioCare ASA ranks #852 out of 1533 companies in the Consumer Packaged Goods industry, placing it in the top 55.6%.
Is Hofseth BioCare ASA's 3-Year EPS without NRI Growth Rate too high?
Hofseth BioCare ASA's current 3-Year EPS without NRI Growth Rate is 3.70%. The Consumer Packaged Goods industry median 3-Year EPS without NRI Growth Rate is 7.20. Hofseth BioCare ASA's value of 3.70% is 48.6% below this industry median. Based on the distribution chart, Hofseth BioCare ASA ranks #852 out of 1533 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Hofseth BioCare ASA has a GF Score™ of 60/100, reflecting its overall financial health beyond just this single metric.
How does Hofseth BioCare ASA's 3-Year EPS without NRI Growth Rate compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Hofseth BioCare ASA ranks #852 out of 1533 companies for 3-Year EPS without NRI Growth Rate. This places Hofseth BioCare ASA in the lower half of its industry. The industry median 3-Year EPS without NRI Growth Rate is 7.20. Hofseth BioCare ASA's value of 3.70% is 48.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Consumer Packaged Goods company?
The median 3-Year EPS without NRI Growth Rate among Consumer Packaged Goods companies is 7.20, based on 1,533 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hofseth BioCare ASA's current 3-Year EPS without NRI Growth Rate of 3.70% is 48.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Hofseth BioCare ASA and its competitors. For the Consumer Packaged Goods industry, the median 3-Year EPS without NRI Growth Rate is 7.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hofseth BioCare ASA's current 3-Year EPS without NRI Growth Rate is 3.70%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hofseth BioCare ASA stock overvalued right now?
Hofseth BioCare ASA (HOFBF) has a current 3-Year EPS without NRI Growth Rate of 3.70%. The stock's GF Value™ is $0.23, compared to a current price of $0.17 — trading 27.6% below its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 3.70% and 48.6% below the Consumer Packaged Goods industry median of 7.20. Hofseth BioCare ASA's overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Hofseth BioCare ASA (HOFBF), the current 3-Year EPS without NRI Growth Rate is 3.70% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hofseth BioCare ASA (HOFBF) Overvalued in 2026?
Based on GuruFocus' analysis, Hofseth BioCare ASA stock appears to be undervalued.
The current stock price of $0.17 is trading 27.6% below its estimated GF Value™ of $0.23.
Key valuation signals for HOFBF:
3-Year EPS without NRI Growth Rate: 3.70%
GF Value™: $0.23 vs. price of $0.17 (27.6% below fair value)
Industry Position: 48.6% below the Consumer Packaged Goods median (#852 of 1533)
No single metric tells the full story. See the HOFBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hofseth BioCare ASA is a Norway-based company engaged in the business of developing, manufacturing, marketing, and selling marine ingredients such as oil, calcium, and protein products. Its brands, which also generate revenue, include salmon oil (OmeGo), water-soluble protein (ProGo), calcium/collagen (CalGo and NT-II), and non-soluble protein (PetGo), all of which are produced in the Midsund plant. The firm sells its products to various segments of the human nutrition market, such as sports nutrition, supplements, and health foods, as well as to the market within nutrition for the pet and feed industry. Geographically, the company generates maximum revenue from Europe, followed by North America and Asia.
60GF Score
Get the complete analysis for HOFBF
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HOFBF has been successfully added to your 
